Various cellular and molecular events underlie the elevation and fusion of the developing palate that occurs during embryonic development. This includes convergent extension, where the medial edge epithelium is intercalated into the midline epithelial seam. We examined the expression patterns of Wnt11 and Fgfr1b -which are believed to be key factors in convergent extension -in mouse palate development. Wnt-11 overexpression and beads soaked in SU5402 (an Fgfr1 inhibitor) were employed in in vitro organ cultures. The results suggested that interactions between Wnt11 and Fgfr1b are important in modulating cellular events such as cell proliferation for growth and apoptosis for fusion. Moreover, the Wnt11 siRNA results showed that Wnt11-induced apoptosis was necessary for palatal fusion. In summary, Fgfr1b induces cell proliferation in the developing palate mesenchyme so that the palate grows and contacts each palatal shelf, with negative feedback of Fgfs triggered by excessive cell proliferation then inhibiting the expression of Fgfr1b and activating the expression of Wnt11 to fuse each palate by activating apoptosis.
Introduction
Various cellular and molecular mechanisms underlie the elevation and fusion of the palate shelves that are integral to normal mammalian palatogenesis (Taniguchi et al., 1995; GritliLinde, 2007; Lee et al., 2007) . Two palatal shelves grow from the internal surfaces of the maxillary primordia once the development of the secondary palate is initiated, and at embryonic day 13.5 (E13.5) in mouse they appear vertically on each side of the tongue, elevating to a horizontal position above the tongue at E14.0 (Ferguson, 1987) . From E14.0 to E14.5 the palatal shelves make contact and start the fusion necessary for correct morphogenesis (Johnston and Bronsky, 1995) , and by E14.5 they are fused with one another from the middle region to the anterior and posterior regions to transform the medial edge epithelium (MEE) into the midline epithelial seam (MES) (Martýnez-Alvarez et al., 2000; Chou et al., 2004) . Then, at E15.5, the MES is completely removed from the fused palate. The fate of the MEE, which is known to form the MES upon palatal shelf fusion, is still debated. Previous studies have revealed that the cleft secondary palate originates from a failure of signaling molecules and their receptors to control proliferation and fusion (Thyagarajan et al., 2003; Yu et al., 2005; Chai and Maxson, 2006) . Several mutation studies have revealed that a cleft palate results from intrinsic disruptions to the cellular and molecular events controlling palatal shelf growth, elevation, or fusion (Gritli-Linde, 2007) . Fgf10 −/− mice show cleft palate because of abnormal fusion between the palatal shelves and the tongue or mandible . Moreover, several defects in craniofacial development, including cleft palate, have been observed in skeletal preparations of Wnt1 and Fgfr1 mutant newborns (Trokovic et al., 2003) .
The sequence of morphological changes in palatogenesis can be considered similar to processes in other types of organogenesis, such as body axis formation, which is also called convergent extension (Tudela et al., 2002) . Convergent extension is broadly defined as the process in which a tissue narrows along one axis and lengthens in the perpendicular axis and is critical to the formation of the vertebrate body axis (Keller et al., 1985; Wallingford et al., 2002) . Signaling molecules such as Wnt11 and Fgfr1 are closely associated with convergent extension movement during other types of organogenesis, including mouse kidney development (Majumdar et al., 2003; Chi et al., 2004) .
The Wnt gene family encodes a conserved class of secreted signaling molecules and is considered to be one of the major gene families essential for correct embryonic pattern and organogenesis (Wodarz and Nusse, 1998; Maye et al., 2004; Yue et al., 2006) . Wnt11 promotes the calcium pathway (Du et al., 1995; He et al., 1997; Maye et al., 2004; Nelson and Nusse, 2004) that is involved in cell adhesion (Torres et al., 1996) and inhibition of the canonical Wnt signaling pathway (Ishitani et al., 2003; Widelitz, 2005) . Wnt11 is also essential for the canonical Wnt pathway activity in dorsal axis formation (Tao et al., 2005) . However, the expression pattern and function of Wnt11 in palatogenesis have not been elucidated.
In this study, we focused on the interaction with the Wnt pathway since FGF/Wnt cross-talk is emerging as an important nexus in the regulation of various biological processes. Wnt signaling is reported to be closely linked to Fgf signaling in the development of other organs, such as controlling the elongation of digits and tip formation . Therefore, it is certain that Fgf expression is closely related to Wnt signaling during tip formation, which represents genetic evidence of a molecular link between the Wnt and Fgf signaling pathways in the patterning of the nascent mesoderm. Moreover, members of the Fgf family regulate Snail, which is the key modulator of cell survival during palate development (Rice et al., 2004 ) and a regulator of epithelial-mesenchymal transformation (EMT) during gastrulation (Carver et al., 2001) .
To investigate the molecular interactions between Wnt11 and Fgfr1b, we employed an overexpression method as a gain of function and treatment with pharmacological inhibitors as a loss of function with an in vitro palate culture system. Moreover, we treated Wnt11 small interfering RNA (siRNA) during in vitro palate culture to confirm the functional significance of Wnt11 in regulating palatal fusion. This study revealed the precise functions of cellular modulations controlled by the expression of specific genes, with the findings elucidating the unique genetic encoding underlying palatal development.
Materials and methods
All experiments complied with the guidelines of the Intramural Animal Use and Care Committee, College of Dentistry, Yonsei University.
Animals
Adult ICR mice were housed in a temperature-controlled room (22°C) under artificial illumination (lights on from 05:00 to 17:00 h) and at 55% relative humidity with access to food and water ad libitum. The embryos were obtained from time-mated pregnant mice. E0 was designated as the day on which the presence of a vaginal plug was confirmed. Embryos at developmental stage E13.5-E15.5 were investigated.
In vitro organ culture
The palatal shelves were isolated from E13.5 mouse maxillae and cultured in medium without fetal bovine serum at 37°C and 5% CO 2 for 48 h using a slight modification of the culture method reported by Trowell (Taya et al., 1999) . The culture medium (DMEM/F12, Gibco) was supplemented with 20 μg/ml ascorbic acid (Sigma) and 1% penicillin/streptomycin and was renewed every 24 h. Tissues were then fixed and processed for in situ hybridizations, TUNEL assay, and immunohistochemistry. At least 10 specimens were examined in each experiment.
Whole-mount in situ hybridization
Specimens were fixed overnight in 4% paraformaldehyde in phosphatebuffered saline (PBS). For in situ hybridization the specimens were treated with 20 μg/ml proteinase K for 3 min at room temperature (Kim et al., 2005) . Antisense RNA probes were labeled with digoxigenin (Roche). After in situ hybridization, the specimens were cryosectioned at a thickness of 25 μm. At least five specimens were examined in each stage.
Expression constructs
pEGFP-N1 (Clontech) was used for tagging Wnt11 protein with EGFP. Plasmid DNA was purified using a plasmid purification kit (Qiagen) and dissolved in TE [10 mM Tris-HCl (pH 8.0) and 0.25 mM EDTA].
Electroporation of organ cultures
The Wnt-11 expression construct (1 μg/μl) in PBS was injected into both palatal epithelium and mesenchyme using a microcapillary needle, and 20-ms current pulses were applied using an electroporator. Before the injection, fast green (diluted 1:10,000; Sigma) was added to the DNA solution for visualization within the tissue. At least 10 specimens were examined in each experiment.
Bead implantation
AG-1X2 (Bio-Rad Laboratories) formate-derived beads were incubated in 10 mM SU5402 (Calbiochem) for 1 h at room temperature. Beads were implanted on the palatal shelf at E13.5. After 48 h of culture in vitro, the palate was used for whole-mount in situ hybridization, TUNEL assay, and immunohistochemistry. At least 10 specimens were examined in each experiment.
Immunohistochemistry and TUNEL assay
The specimens were embedded in OCT compound using conventional methods. Sections (7 μm thick) of the specimens were incubated at 4°C overnight with the primary mouse monoclonal antibody against proliferating cell nuclear antigen (PCNA, NeoMarkers). After washing with PBS, the specimens were allowed to react with biotinylated goat antimouse immunoglobulins and streptavidin peroxidase at room temperature for two consecutive 10-minute incubations. Finally, the specimens were visualized using a 3,3′-diaminobenzidine (DAB) reagent kit (Zymed). A TUNEL assay was performed using an in situ cell apoptosis detection kit (Trevigen) following the manufacturer's instructions. The 7-μm-thick sections were treated with proteinase K [in 10 mM Tris-HCl (pH 8.0)] at a concentration of 20 μg/ml for 15-20 min at room temperature. The samples were then incubated with the labeling reaction mixture at 37°C for 1 h and streptavidin-HRP solution for 10 min at room temperature. DAB was used as a substrate solution to detect the sites of in situ apoptosis under a light microscope. At least 10 specimens were examined in each experiment.
In vitro organ culture with the apoptosis inhibitor z-VAD-fmk
In the experimental treatments, media were supplemented with 25 μM, 50 μM, or 100 μM z-VAD-fmk (FK-009 z-VAD (OMe)-CH2F O-methylated, Enzyme Systems Products) in DMSO (Sigma, USA) for 2 days. At least 10 explants for each concentration of the z-VAD-fmk-treated group and the control group were observed in each experiment.
Small interfering RNA treatment
A 500 nM siRNA solution was prepared as follows. A siRNA stock (50 μM) was diluted with DMEM/F12 medium containing transfection reagent (siPORT™NeoFX™, Ambion) and then incubated for 10 min at room temperature. Scrambled control siRNA (Silencer® Negative-Control siRNA, Ambion) and Wnt11 siRNA (Silencer® Predesigned siRNA; siRNA ID 65306, Ambion) were applied at a final concentration of 500 nM (Shiomi et al., 2006; Nakajima et al., 2007) . siRNA solutions (2 ml) were applied to each culture plate containing five sets of paired palatal shelves. The palatal fusion process was confirmed by characterizing the MES region after culturing for 72 h from E13.5.
Real-time quantitative PCR
Total RNA was isolated from the cultured palate using the RNeasy® Mini Kit (Qiagen). For cDNA synthesis, reverse transcription was performed using M-MuLV reverse transcriptase (New England BioLabs). Real-time quantitative PCR (RT-qPCR) was performed using Thermal Cycler Dice™ Real Time System (TP800, Takara) with SYBR Premix EX Taq™ (Takara). The amplification program consisted of 45 cycles of denaturation at 95°C for 5 s, annealing at 55°C for 20 s, and extension at 72°C for 20 s. The results of RTqPCR for each sample were normalized β-actin. The data were analyzed with the Thermal Cycler Dice™ Real Time System analysis software (Takara). The results were expressed as normalized ratios. The primer sequences of the genes are as follows: β-actin, 5′-ATTGCCGACAGGATGCAGA-3′ (forward) and 5′-GAGTACTTGCGCTCAGGAGGA-3′ (reverse); Wnt11 (designed by Takara Bio), 5′-GGATCCCAAGCCAATAAACTGATG-3′ (forward) and 5′-TTGAGGTCAGCAGCCACGTC-3′ (reverse); and Fgfr1b, 5′-GGGAATTAA-TAGCTCGGATGA-3′ (forward) and 5′-ACGCAGACTGGTTAGCTTCA-3′ (reverse). Data were expressed as mean ± SD. The mean expression levels were compared between the experimental and control groups using ANOVA (SPSS 10.0), with a probability value of P b 0.05 (Tukey's HSD test) being considered statistically significant.
Results

Expression patterns of Wnt11 and Fgfr1b in the developing mouse palate
Wnt11 expression was examined by in situ hybridization at E13.5, E13.75, E14.0, and E14.5 (Figs. 1A-H). Each specimen was frontally sectioned at the level of the black dotted lines in the figure (Figs. 1A-P). At E13.5, Wnt11 was not expressed in the anterior to posterior regions of the secondary palate (Fig. 1A ) or in either the epithelium or mesenchyme of the palatal shelf (Fig. 1E) . However, at E13.75 the palatal shelves were elevated above the tongue but were still not in contact with each other, and Wnt11 was strongly expressed in the MEE region of the palatal shelves (Fig. 1B) and on the nasal to oral sides of the palatal shelf epithelium (Fig. 1F) . At E14.0, the middle parts of the palatal shelves began to make contact with each other. Wnt11 was expressed in the epithelium of the MEE region of both the contacted and noncontacted parts of the palatal shelves (Fig.  1C) , and the expression was strong in the MES and on the nasal and oral sides of the fusion region in the palatal epithelium ( Fig.  1G ). At E14.5, Wnt11 expression was observed along the entire fusion line (Fig. 1D ) and was strong on the oral and nasal sides of the palatal epithelium (Fig. 1H) but weak in the MES region.
At E13.5, Fgfr1b was expressed from the anterior to middle regions of the mouse secondary palate (Fig. 1I) . Frontal sections showed that Fgfr1b was expressed in the palatal mesenchyme of the MEE region (Fig. 1M) . The expression pattern of Fgfr1b did not change after elevation and fusion (Figs. 1J-L) . At E13.75, Fgfr1b was expressed from the anterior to middle regions of the palatal shelves (Fig. 1J ) and in the palatal mesenchyme, similar to E13.5 (Fig. 1N) . At E14.0, Fgfr1b was expressed from the anterior to middle regions of the secondary palate (Fig. 1K) . Interestingly, Fgfr1b was not expressed at all in the region of palatal contact of both the epithelium and mesenchyme (Fig. 1O) . At E14.5, Fgfr1b was expressed throughout the anterior and posterior regions of the secondary palate (Fig. 1L) . Frontal sections revealed strong Fgfr1b expression in the mesenchymal region (Fig. 1P) .
Alteration of gene expression patterns after applying SU5402-soaked beads and Wnt11 overexpression
In order to compare the molecular regulation between Wnt11 and Fgfr1b, Wnt-11 was artificially overexpressed in the developing secondary palate, and beads soaked with the Fgfr1 inhibitor SU5402 were implanted in in vitro organ cultures at E13.5 for 48 h ( Figs. 2A-D) . In culture, the two palatal shelves grew toward each other to fill the initial gap of 0.04 mm to establish palatal contact. In this stage, the MEE region also grew and migrated with the palatal shelves. This made it difficult to inject the expression construct of Wnt-11 and to implant SU5402 beads exactly at the MEE position. Wnt11 was expressed only in the palatal epithelium, in the MEE and MES regions. Therefore, we attempted to induce Wnt-11 overexpression only in the palatal epithelium, avoiding the mesenchyme. However, it was technically impossible to microinject the Wnt-11 construct only in the epithelium, and hence the construct was injected into both the palatal epithelium and mesenchyme.
Wnt-11 was overexpressed, as shown within the red dotted circle in Fig. 2A . Wnt-11 was successfully transfected, as judged by GFP expression (Fig. 2A′) . Moreover, RT-qPCR was performed to confirm whether the Wnt-11 was successfully transfected (Fig. 2E) . The level of Wnt11 differed significantly between the Wnt-11 overexpressed and control groups. Relative to the control on the right side ( Fig. 2A) , Wnt-11 overexpression led to the inhibition of Fgfr1b expression at the anterior to middle regions after 48 h. The expression of Fgfr1b was weaker on the Wnt-11 overexpressed side than on the control side (Fig.  2C) . Moreover, the expression of Wnt11 was upregulated at 48 h after implanting SU5402-soaked beads (Fig. 2B) , and SU5402 strongly induced Wnt11 expression on the oral side of the palatal epithelium and weakly in the underlying mesenchyme (Fig. 2D) . These results indicate that Wnt11 is related to the Fgfr1 pathway.
Alterations to cellular events after treatment with SU5402-soaked beads and Wnt11 overexpression
Cell death was examined in control and Wnt-11 overexpressed specimens (Fig. 3A) . Significantly, many apoptotic cells were detected in both the palatal epithelium and mesenchyme on the Wnt-11 overexpressed domain compared to the control domain (Fig. 3A) . In addition, TUNEL-positive cells were observed in the epithelium of the midline region, indicating fusion of the two developing palates. On the Wnt-11 overexpressed side, strong positive reactions for cell death were identified in the epithelium and underlying mesenchyme (Fig. 3C ), while few TUNELpositive cells were observed on the control side (Fig. 3D) . The vector control showed that TUNEL-positive cells were not altered at E13.5 (data not shown). On the other hand, the number of PCNA-positive cells differed between the experimental and control sides after 48 h (Fig. 3G) . The number of PCNA-positive was clearly lower in the Wnt-11 overexpressed region than in the control (Figs. 3I and J) . To determine whether Fgf signaling is involved in the maintenance and/or induction of cell death and in proliferation in secondary palate development, beads soaked in SU5402 (10 mM) were implanted on one side of the palatal shelf and cultured for 48 h (DMSO as the control), and TUNEL and PCNA were applied to the developing palate (Figs. 3B and H) . SU5402 altered the number of apoptotic cells (Fig. 3B) . After SU5402 beads implantation at E13.5, the number of TUNELpositive cells was clearly higher than in the control after 48 h (Figs. 3E and F) . SU5402 also altered cell proliferation (Fig.  3H) . The number of proliferating cells was lower around SU5402-soaked beads than in the control during palate development (Figs. 3K and L) . The numbers of TUNEL-and PCNA-positive cells were not altered in the control after implanting DMSO-soaked beads (data not shown).
Inhibition of apoptosis by z-VAD-fmk treatment disrupted palate fusion
In order to investigate the effect of z-VAD-fmk treatment as an inhibitor of apoptosis, developing palates were cultured in media containing 25 μM, 50 μM, or 100 μM z-VAD-fmk for 48 h. H-E staining of serial frontal sections revealed differences between the DMSO controls and z-VAD-fmk-treated specimens (Figs. 4A-C) . In the controls, developing pairs of palates were completely fused after 48 h (n = 9/10) (Fig. 4A) . The fate of the MES in the experimental group clearly differed with the dose, with z-VAD-fmk at a low concentration (25 μM) not inhibiting palatal fusion (n = 11/14), with some MES cells remaining (arrowheads in Fig. 4B ), while MES cells still remained (arrowheads in Fig. 4C ) with z-VAD-fmk at a high concentration (50 μM) (n = 12/14) (Fig. 4C) , with similar results for 100 μM z-VAD-fmk (n = 11/11) (data not shown).
The number of TUNEL-positive cells was counted in a 100 μm 2 region of both control and z-VAD-fmk-treated specimens. The number of apoptotic cells was significantly lower after z-VAD-fmk treatment than in the DMSO control (Figs. 4D-F, and data not shown), with the difference increasing with the concentration of z-VAD-fmk. There were 8.7 TUNEL-positive cells/100 μm 2 in the palate of DMSO control specimens (Fig. 4D , and data not shown), but 4.6 cells/ 100 μm 2 after treatment with 25 μM z-VAD-fmk. However, palatal shelves were fused with the MES particles (arrowheads in Fig. 4B ) only on the oral and nasal sides (Figs. 4B and E, and data not shown). Moreover, there were only 2 cells/100 μm 2 in specimens treated with 50 μM or 100 μM z-VAD-fmk (Fig. 4F , and data not shown).
Wnt11 knockdown using siRNA
To determine the function of Wnt11 during palatogenesis, we performed a gene knockdown investigation using Wnt11 siRNA (siRNA ID 65306, Ambion). Wnt11 siRNA was applied at 500 nM to palatal shelves at E13.5, which were then cultured for 72 h. After in vitro culture, we performed H-E staining to identify alterations to the pattern of palatogenesis (Figs. 5A-C ). There were no morphological differences between the control siRNA treatment group and the control group (n = 13/15) (Figs. 5A and B), with the MES completely disappearing and the palatal shelves fusing. However, there were morphological differences between the Wnt11 siRNA treatment group and the control siRNA treatment group (Figs. 5B and C). After treatment with 500 nM Wnt11 siRNA, the MES was still detected in the midline of the palate (n = 15/15) (arrowheads in Fig. 5C ). In order to understand the precise relationship between Wnt11 and apoptosis, we performed TUNEL staining after treatment with Wnt11 siRNA (Figs. 5D-F) . In control and control siRNA, apoptotic bodies decreased with the disappearance of the MES (Figs. 5D and E) . As expected, Wnt11 knockdown by siRNA inhibited apoptosis in the remaining MES (Fig. 5F ). RT-qPCR was used to examine the effectiveness of the siRNA system. Significant differences were found after Wnt11 siRNA treatment. The level of Wnt11 was lower in the 500 nM Wnt11 siRNA treatment group than in the control and control siRNA treatment groups (n = 24) (Fig. 5G) . In order to confirm the relationship between Wnt11 and Fgfr1b in palatogenesis, we used RT-qPCR to evaluate the expression level of Fgfr1b after Wnt11 siRNA treatment. The expression level of Fgfr1b was dramatically higher in the Wnt11 siRNA treatment group than in the control and control siRNA treatment groups (n = 15) (Fig. 5H) .
Discussion
Expression patterns of Wnt11 and Fgfr1b in the developing secondary palate
Convergent extension has been examined during palatogenesis when MEE cells intercalate to the MES during palatal fusion (Tudela et al., 2002) . Convergent extension as regulated by Wnt11 is also critical to the formation of the vertebrate body axis (Jopling and den Hertog, 2005) . The relationships between convergent extension and the Wnt11 and Fgfr1 genes in gastrulation cell movements have been reported (Chung et al., 2005; Jopling and den Hertog, 2005) . In addition, Wnt11 and Fig. 2. (A, C) Overexpressed Wnt-11 alters Fgfr1b expression pattern. Electroporation is applied between the anterior and middle regions of the palate (red dotted circle). All specimens are electroporated at E13.5 and then incubated for 48 h. Wnt-11 is successfully transfected, as indicated by the GFP expression (A′). After Wnt-11 overexpression, Fgfr1b expression is downregulated in these regions (arrows). (B, D) SU5402-soaked beads (10 mM, asterisk) are implanted into the palate at E13.5 and the specimens are then incubated for 48 h. Expression of Wnt11 is upregulated strongly in the epithelium and weakly in the mesenchyme by the implantation of SU5402-soaked beads (arrowheads). (E) Expression levels of Wnt11 are examined by RT-qPCR in the palate at E13.5 after 48 h of culturing. Wnt11 expression levels increase dramatically after Wnt-11 overexpression relative to control groups. *P b 0.05 as determined by ANOVA; asterisk, bead; red dotted circle, DNA injection region; white dotted line, boundary of the cultured palate; scale bars: A, B, 500 μm; C, D, 100 μm.
Fgfr1b play essential roles in vertebrate development, including the branching morphogenesis in the kidney of the mouse (Majumdar et al., 2003; Chi et al., 2004; Tao et al., 2005) . In the present study, we hypothesized that Wnt11 and Fgfr1b were involved in palatogenesis, whose cellular mechanisms are similar to convergent extension. While Wnt11 and Fgfr1b play important roles in convergent extension (Trokovic et al., 2003) , the precise molecular interactions between Wnt11 and Fgfr1b underlying palatogenesis have not been elucidated. In order to understand the function of Wnt11 and Fgfr1b, we examined gene expression patterns between E13.5 and E14.5 using in situ hybridization since these developmental stages are critical to palate formation. Prior to fusion, the expression patterns of Wnt11 in the margin of the palatal shelf epithelium suggested that Wnt11 is involved in the fusion of the palatal shelves. In contrast, Fgfr1b was expressed in the developing palatal mesenchyme from the anterior to posterior regions. Particularly at E14.0, when palatal contact is initiated, Fgfr1b was not expressed in either the palatal epithelium or mesenchyme along the palatal margin (Fig. 1) . These temporal expression patterns of Wnt11 and Fgfr1b during palate development suggest that they play important roles through interactions or cascade pathways.
Wnt11 and Fgfr1b modulate the cellular events during palatogenesis
To clarify the molecular interactions between Wnt11 and Fgfr1b during palatogenesis, Wnt-11 overexpression -representing an enhancement of the function of Wnt11 -was examined using an electroporation method. The results clearly showed that the expression of Fgfr1b was downregulated in the developing palate (Fig. 2) . Moreover, knockdown using Wnt11 siRNA induced the intensity of Fgfr1b (Fig. 6H) , which suggests that a specific pathway of Wnt11 regulates Fgfr1b during palatogenesis. Wnt11 expression was upregulated by the implantation of SU5402-soaked beads, concomitant with the loss of function of Fgfr1 (Fig. 2) . Thus, mesenchymal expression of Fgfr1b would negatively regulate the epithelial expression of Wnt11. These altered expression patterns of Wnt11 and Fgfr1b suggest that Fgfr1b and Wnt11 negatively regulate each other during palatogenesis.
Based on the specific expression patterns of Wnt11 in the MEE and MES during palatogenesis, we hypothesized that Wnt11 is involved in palatal fusion, which is induced by apoptosis. Recent studies have shown that apoptosis plays important roles in palatal fusion (Vaziri Sani et al., 2005) and that members of the Wnt family regulate cell death both positively and negatively (Lobov et al., 2005) . In order to understand the function of Wnt11, electroporation was performed for overexpression of Wnt-11 away from the MEE. Naturally, Wnt11 was expressed in the MEE and MES regions of the epithelium (Fig. 1) . Apoptotic cells were also detected in the MES where Wnt11 expressed region (Fig. 3) . We therefore attempted to avoid overlap between normal Wnt11 expressions and overexpressed Wnt-11, injecting the Wnt-11 expression construct away from the MEE. TUNEL staining after Wnt-11 overexpression revealed that Wnt11 modulates cell death in palatogenesis. Inhibition of Fgfr1 by SU5402 altered cell proliferation and apoptosis in the developing palate, suggesting that the Fgfs influence the cellular events including cell proliferation and apoptosis in palate development either directly or indirectly. These results are consistent with previous studies that have provided evidence of molecular interactions between Fgf and Fgfrs in palatogenesis (Garcia-Maya et al., 2006; Ziv et al., 2006) .
These results suggest that cell proliferation -which is reported to be closely related to the elevation of the developing palate -would be regulated in part by Fgfr1b, whereas Wnt11 potentially regulates palatal fusion by mediating cell death. Furthermore, the relationship between Fgfr1b and Wnt11 is required for correct processes of palatal development, such as proliferation and fusion induced by apoptosis.
Apoptosis for palatal fusion is modulated by molecular interactions between Wnt11 and Fgfr1b
Vaziri Sani et al. (2005) reported that the fate of the MES during palatal development is still controversial. Previous studies showed that apoptosis eliminates some MEE cells, which results in the correct migration and differentiation during palatal fusion (Mori et al., 1994; Taniguchi et al., 1995; Cuervo and Covarrubias, 2004) . However, Takahara et al. (2004) used a palate organ culture with apoptosis inhibitors to demonstrate that cell death is not required for mammalian palatogenesis. Moreover, there is ultrastructural and molecular evidence of EMT in the disappearing MES cells (Martýnez-Alvarez et al., 2000) , although more recent in vivo genetic fate-mapping results showed that the occurrence of EMT is mutually contradictory during palatal fusion (Vaziri Sani et al., 2005; Jin and Ding, 2006) . Based on our in vitro Wnt-11 overexpression results, we suggest that Wnt11 induces apoptosis in the palatal epithelium and mesenchyme through inhibition of Fgfr1b, which plays important roles in cell proliferation. However, Wnt-11 overexpression was not sufficient to elucidate function of apoptosis in palatal fusion.
We examined the precise role of apoptosis in palatal fusion by treating samples with the pancaspase inhibitor z-VAD-fmk, which blocked the apoptosis induced by p21 (Wood and Newcomb, 1999) (Fig. 4) . The H-E staining results suggest that treatment with z-VAD-fmk at a concentration greater than 50 μM disrupted palate fusion by decreasing the number of apoptotic cells.
Based on previous studies (Shiomi et al., 2006; Nakajima et al., 2007) , siRNA treatment was used in the present study to examine the functional significance of Wnt11 in regulating palatal fusion (Fig. 5) . Majumdar et al. (2003) reported that Wnt11 mutant mice showed various problems, such as a smaller kidney and ureteric and kidney branching defects. However, cleft palate has not been reported in Wnt11 transgenic mice. In the present study, we treated with Wnt11 siRNA at E13.5 for Fig. 6 . The molecular interactions between Wnt11 and Fgfr1b modulate various cellular events including cell proliferation and apoptosis to ensure correct development. Black blunt arrow, previous finding; blue arrow, positive modulation; e, epithelium; m, mesenchyme; red blunt arrow, negative modulation. 72 h. One advantage of this system is that it may allow the examination of gene regulation in a time-and tissue-specific manner. Our use of this in vitro culture system with Wnt11 siRNA confirmed that Wnt11 was closely related to palatal fusion. As we hypothesized, knockdown of Wnt11 resulted in the failure of palatal fusion, which also occurred after treatment with z-VAD-fmk. After in vitro culture at E13.5 for 72 h, palatal shelves were completely fused with elimination of the MES via apoptosis (Figs. 3A, 5D and E). However, after Wnt11 siRNA treatment, apoptotic cells were not detected even when the MES did not disappear (Fig. 5F ). These results suggest that Wnt11 is a key factor for palatal fusion through the induction of apoptosis.
Molecular interactions govern cellular modulations in palatogenesis
Our results appear to demonstrate that cellular modulations controlled by molecular interactions between Wnt11 and Fgfr1b are important to the correct development of the palate in three critical phases during palatogenesis. In the first (growth) phase between E13.5 and E14.0, Fgfr1b induce cell proliferation and inhibit Wnt11 expression (Fig. 6A) . Inhibitory feedback loops downstream of FGF signaling factors regulate signal propagation via a MAP kinase cascade downstream of FGF receptor activation (Eblaghie et al., 2003) . In the second (contact) phase at E14.0, negative feedback of Fgf-induced cell proliferation would gradually inhibit Fgfr1 expression over time (Garcia-Maya et al., 2006) , which might in turn cause the gradual expression of Wnt11, inducing apoptosis in the adjacent epithelium (Fig. 6B ). In the third (fusion) phase at E14.5, Wnt11-induced apoptosis in the epithelium (MES) would be eliminated over time, resulting in Fgfr1b being gradually expressed for growth of the fused palate (Fig. 6C) . The results of z-VAD-fmk treatment revealed that Wnt11-mediated apoptosis is closely related to palate fusion in this third phase. Interactions between Wnt11 and Fgfr1b could represent a pivotal cellular-control mechanism for achieving the precise morphogenesis of the secondary palate. The model is steady with the data at hand, but given the rapid advancing of the field, no doubt the model will need some dynamic remodeling over time as additional pathways and molecular cross-talk emerge.
An understanding of the unique developmental processes underlying palatogenesis will help to elucidate the fundamental molecular mechanisms underlying cleft palate. We propose that Wnt/Fgfr cross-talk plays an important, cell-autonomous role in regulating the fate of MEE cells during palatogenesis in both mice and humans. Future studies should examine the factors that play fundamental roles in mediating palate development using experimental model system, such as microarray, to understand the precise molecular mechanisms underlying palatal development.
